Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03444753
Title An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 0003 La Jolla California 92093-0698 United States Details
Local Institution Orange California 92868 United States Details
University of California Davis Medical Center Sacramento California 95817 United States Details
Local Institution New Haven Connecticut 06520 United States Details
Local Institution Detroit Michigan 48202 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Local Institution Portland Oregon 97239 United States Details
Local Institution Pittsburgh Pennsylvania 15232-1305 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field